USCWA
DNMR

U.S. Capital Wealth Advisors’s Danimer Scientific, Inc. DNMR Stock Holding History

U.S. Capital Wealth Advisors’s Portfolio DNMR Stock Details DNMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5
Closed -$358 – 1576
2022
Q4 		$358 Buy
+5
New +$473 ﹤0.01% 1581

Other funds holding DNMR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TA
Teramo Advisors Naples, Florida $529M AUM 20.59% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
CIA
Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return

U.S. Capital Wealth Advisors's DNMR Position: Q1 2023 in Review

U.S. Capital Wealth Advisors sold out of Danimer Scientific, Inc. (DNMR) in Q1 2023, closing a stake of 5 shares — an estimated $358 sold.

U.S. Capital Wealth Advisors first reported a position in DNMR in Q4 2022 and held it in 1 quarter. The position peaked at $358 in Q4 2022. 160 funds tracked by Wall St. Rank hold DNMR as of Q1 2023.

  • U.S. Capital Wealth Advisors reported no remaining Danimer Scientific, Inc. position as of Q1 2023 after selling out during the quarter.
  • U.S. Capital Wealth Advisors sold 5 Danimer Scientific, Inc. shares in Q1 2023, an estimated $358.
  • U.S. Capital Wealth Advisors first reported a position in Danimer Scientific, Inc. in Q4 2022 and held it in 1 quarter.
  • U.S. Capital Wealth Advisors's Danimer Scientific, Inc. position peaked at $358 in Q4 2022.
  • 160 funds tracked by Wall St. Rank held Danimer Scientific, Inc. as of Q1 2023.

Based on U.S. Capital Wealth Advisors's 13F filing for Q1 2023, filed 11 May 2023.